uracil has been researched along with Lung Neoplasms in 244 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of postoperative tegafur-uracil on overall survival (OS) after resection of stage I adenocarcinoma has been shown in clinical trials." | 9.69 | Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis. ( Aoyama, A; Date, H; Date, N; Fujinaga, T; Fukada, T; Hamaji, M; Huang, CL; Ishikawa, M; Katakura, H; Kayawake, H; Kobayashi, M; Kono, T; Matsumoto, A; Menju, T; Miyahara, R; Miyamoto, E; Miyata, R; Morita, S; Nakagawa, T; Nakakura, A; Okumura, N; Sakaguchi, Y; Sakai, H; Shimazu, Y; Sonobe, M; Sumitomo, R; Takahashi, M, 2023) |
| "We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with extensively pretreated metastatic colorectal cancer (mCRC)." | 9.16 | Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. ( Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D, 2012) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 9.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| " This study aimed to assess the efficacy of adding daily oral UFT to gefitinib treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy." | 9.15 | A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy. ( Chen, YM; Chou, KT; Chou, TY; Fan, WC; Lee, YC; Liu, SH; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J; Wu, CH, 2011) |
| "We randomly assigned patients with completely resected pathological stage I adenocarcinoma of the lung to receive either oral uracil-tegafur (250 mg of tegafur per square meter of body-surface area per day) for two years or no treatment." | 9.11 | A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. ( Hamajima, N; Hata, E; Ichinose, Y; Kato, H; Ohta, M; Tada, H; Tsuboi, M; Tsubota, N; Wada, H; Watanabe, Y, 2004) |
| "To determine if the preoperative administration of tegafur and uracil (UFT) to patients with lung adenocarcinoma could induce apoptosis." | 9.11 | Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT). ( Futagawa, T; Izumi, H; Konno, H; Miyamoto, H; Morio, A; Oh, T; Yamazaki, A, 2004) |
| "We report a case of multiple lung metastases from hepatocellular carcinoma(HCC)successfully treated by oral administration of tegafur/uracil(UFT)." | 8.89 | [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil]. ( Hatano, E; Koyama, Y; Takada, Y; Tanabe, K; Taura, K; Uemoto, S, 2013) |
| "Tegafur-uracil (UFT) improves survival in patients with stage I adenocarcinoma of the lung." | 7.85 | The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung. ( Hamada, C; Kato, H; Ohta, M; Tsuboi, M, 2017) |
| "A 65-year-old woman who had diffuse hepatocellular carcinoma(HCC)with tumor thrombus of right portalvein(Vp3) and lung metastases(Stage IVB)was treated by single-agent therapy with tegafur/uracil(UFT)." | 7.76 | [A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil]. ( Adachi, K; Hiramatsu, S; Kurai, O; Miyano, M; Oka, H; Sasaki, E; Yamasaki, T, 2010) |
| "We report two cases of recurrent colorectal cancer in two patients who were treated successfully with a combined oral chemotherapeutic agent folinate/tegafur/uracil (UFT/LV) dosage." | 7.74 | [Two cases of recurrent colorectal cancer treated successfully with folinate/tegafur/uracil (UFT/LV) chemotherapy on an outpatient basis]. ( Hosotaki, K; Shimamoto, M; Tabira, Y; Tamori, Y, 2008) |
| "Adjuvant chemotherapy with uracil-tegafur has been demonstrated to prolong survival among patients with resected lung adenocarcinomas." | 7.74 | Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. ( Date, H; Fujiwara, Y; Hotta, K; Kiura, K; Matsuo, K; Ouchida, M; Soh, J; Suehisa, H; Takata, M; Toyooka, S; Uchida, A, 2007) |
| "A 71-year-old man who had undergone surgery for stage II adenocarcinoma of the lung followed by adjuvant tegafur-uracil (UFT; 300 mg/day) therapy was admitted." | 7.73 | Pulmonary cryptococcosis mimicking pulmonary metastases in a patient treated with Tegafur-uracil after lung cancer surgery. ( Endo, S; Hasegawa, T; Saito, N; Sato, Y; Sohara, Y, 2005) |
| " A phase II clinical trial of this combination using a continuous dosing schedule was carried out in patients with metastatic colorectal cancer." | 6.70 | Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer. ( Benson, AB; Catalano, P; Cornfeld, MJ; Graham, DL; Huang, J; Marsh, JC; O'Dwyer, PJ, 2002) |
| "The effect of postoperative tegafur-uracil on overall survival (OS) after resection of stage I adenocarcinoma has been shown in clinical trials." | 5.69 | Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis. ( Aoyama, A; Date, H; Date, N; Fujinaga, T; Fukada, T; Hamaji, M; Huang, CL; Ishikawa, M; Katakura, H; Kayawake, H; Kobayashi, M; Kono, T; Matsumoto, A; Menju, T; Miyahara, R; Miyamoto, E; Miyata, R; Morita, S; Nakagawa, T; Nakakura, A; Okumura, N; Sakaguchi, Y; Sakai, H; Shimazu, Y; Sonobe, M; Sumitomo, R; Takahashi, M, 2023) |
| "Uracil/tegafur was stopped in December 10, 2005, and docetaxel (taxotere) 50mg/m2 was given in December 12, 2005." | 5.34 | [Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer]. ( Bandoh, S; Kanaji, N, 2007) |
| "To evaluate the antitumor efficacy against metastatic breast cancer of fluoropyrimidines alone and combined with other chemotherapeutic agents, we developed a murine model of breast cancer metastatic to the lung by orthotopically implanting MDA-MB-435S breast tumors into mice." | 5.31 | [Antimetastatic and antitumor effects of fluoropyrimidines alone and combined with taxanes in a murine model of breast cancer metastatic to the lung]. ( Fujioka, A; Fukushima, M; Nakagawa, F; Nukatsuka, M; Ohshimo, H, 2002) |
| "We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with extensively pretreated metastatic colorectal cancer (mCRC)." | 5.16 | Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. ( Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D, 2012) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 5.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| " This study aimed to assess the efficacy of adding daily oral UFT to gefitinib treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy." | 5.15 | A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy. ( Chen, YM; Chou, KT; Chou, TY; Fan, WC; Lee, YC; Liu, SH; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J; Wu, CH, 2011) |
| "To determine if the preoperative administration of tegafur and uracil (UFT) to patients with lung adenocarcinoma could induce apoptosis." | 5.11 | Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT). ( Futagawa, T; Izumi, H; Konno, H; Miyamoto, H; Morio, A; Oh, T; Yamazaki, A, 2004) |
| "We randomly assigned patients with completely resected pathological stage I adenocarcinoma of the lung to receive either oral uracil-tegafur (250 mg of tegafur per square meter of body-surface area per day) for two years or no treatment." | 5.11 | A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. ( Hamajima, N; Hata, E; Ichinose, Y; Kato, H; Ohta, M; Tada, H; Tsuboi, M; Tsubota, N; Wada, H; Watanabe, Y, 2004) |
| "We report a case of multiple lung metastases from hepatocellular carcinoma(HCC)successfully treated by oral administration of tegafur/uracil(UFT)." | 4.89 | [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil]. ( Hatano, E; Koyama, Y; Takada, Y; Tanabe, K; Taura, K; Uemoto, S, 2013) |
| " On the other hand, uracil-tegafur was also shown to improve survival among patients with stage I adenocarcinoma in Japan." | 4.83 | [Adjuvant chemotherapy for non-small cell lung cancer]. ( Ichinose, Y; Okamoto, T, 2006) |
| "Tegafur-uracil (UFT) improves survival in patients with stage I adenocarcinoma of the lung." | 3.85 | The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung. ( Hamada, C; Kato, H; Ohta, M; Tsuboi, M, 2017) |
| "A 65-year-old woman who had diffuse hepatocellular carcinoma(HCC)with tumor thrombus of right portalvein(Vp3) and lung metastases(Stage IVB)was treated by single-agent therapy with tegafur/uracil(UFT)." | 3.76 | [A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil]. ( Adachi, K; Hiramatsu, S; Kurai, O; Miyano, M; Oka, H; Sasaki, E; Yamasaki, T, 2010) |
| "We report two cases of recurrent colorectal cancer in two patients who were treated successfully with a combined oral chemotherapeutic agent folinate/tegafur/uracil (UFT/LV) dosage." | 3.74 | [Two cases of recurrent colorectal cancer treated successfully with folinate/tegafur/uracil (UFT/LV) chemotherapy on an outpatient basis]. ( Hosotaki, K; Shimamoto, M; Tabira, Y; Tamori, Y, 2008) |
| "Adjuvant chemotherapy with uracil-tegafur has been demonstrated to prolong survival among patients with resected lung adenocarcinomas." | 3.74 | Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. ( Date, H; Fujiwara, Y; Hotta, K; Kiura, K; Matsuo, K; Ouchida, M; Soh, J; Suehisa, H; Takata, M; Toyooka, S; Uchida, A, 2007) |
| " Actually, the EGFR tyrosine kinase inhibitor, gefitinib, is well known to be significantly effective for oriental people, including Japanese, female, adenocarcinoma and never-smoker, suggesting an inherited difference." | 3.74 | [Differences in the therapeutic strategies for lung cancer between Europe/United States and Japan]. ( Hanibuchi, M; Sone, S; Tomimoto, H; Yano, S, 2007) |
| "A 71-year-old man who had undergone surgery for stage II adenocarcinoma of the lung followed by adjuvant tegafur-uracil (UFT; 300 mg/day) therapy was admitted." | 3.73 | Pulmonary cryptococcosis mimicking pulmonary metastases in a patient treated with Tegafur-uracil after lung cancer surgery. ( Endo, S; Hasegawa, T; Saito, N; Sato, Y; Sohara, Y, 2005) |
| "One patient with pulmonary metastasis from colon cancer and one with para-aortic lymph node metastasis were treated with a combination of irinotecan and UFT." | 3.71 | [Two patients with recurrent colon cancer who underwent surgery following a combination of irinotecan and UFT]. ( Ishikawa, K; Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Saguchi, T; Suzuki, T; Yamamoto, T; Yasuda, S, 2002) |
| " Using a murine dorsal air sac (DAS) assay, we have previously shown that UFT and its metabolites, gamma-hydroxybutyric acid (GHB) and 5-fluorouracil (5-FU), inhibited the angiogenesis induced by murine renal cell carcinoma." | 3.71 | gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. ( Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K, 2001) |
| "The clonogenic activity of tumors and blood marrow cells has been studied in experiments on CBA, BALB/C and C57B1/6 mice with the Ehrlich adenocarcinoma and Lewis lung carcinosarcoma treated with adaptogenic drugs of Rhodiola Rosea extract, a synthetic analog of Rhodiola phenol derivative, methyluracil and their combinations with cyclophosphamide." | 3.68 | [Changes in clonogenic properties of bone marrow and transplantable mice tumor cells during combined use of cyclophosphane and biological response modifiers of adaptogenic origin]. ( Shakhov, VP; Udintsev, SN, 1990) |
| "A 74-year-old female with lung metastasis of breast cancer was treated with chemo-endocrine therapy (intravenous administration of epirubicin at 30 mg/2w, oral administration of UFT at 400 mg/day, alternate oral administration of medroxyprogesterone acetate at 800 mg/day and tamoxifen at 40 mg/day) and immuno-therapy (intravenous administration of lentinan at 2 mg/w)." | 3.68 | [A case of breast cancer with thrombosis during treatment of lung metastasis]. ( Kosaka, A; Sakaguchi, T; Watahiki, Y, 1993) |
| "A 34-year-old female patient with breast cancer metastasizing to bone had a remission after a course of treatment with medroxyprogesterone acetate (MPA) 1,200 mg/day, but again had a metastasis to the lungs." | 3.68 | [A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy]. ( Harada, N; Kanda, K; Kida, H; Narita, K; Uchimura, M; Waki, S, 1990) |
| "A phase II evaluation of UFT, a mixture of tegafur and uracil, was performed in 13 patients with non-small cell lung cancer (eight patients with adenocarcinoma and five patients with squamous cell carcinoma)." | 3.67 | [A phase II study of UFT in non-small cell lung cancer]. ( Hojo, F; Inoue, I; Kimura, K; Nakamura, Y; Nakanishi, S; Noda, Y; Shimizu, E; Sone, S; Yagi, M; Yamasaki, K, 1986) |
| "Patients with clinical stage II or III rectal cancer were treated with radiotherapy of 44 Gy in 22 fractions." | 2.79 | Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study. ( Chen, HC; Chen, HH; Chen, WT; Chien, CR; Hsiao, CF; Lee, HH; Lin, TC; Lin, TY; Liu, TW; Wang, LW, 2014) |
| "Grade 3/4 neutropenia was observed in 12% (4/32), grade 3/4 thrombocytopenia in 15% (5/32), without febrile neutropenia." | 2.74 | Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study. ( Aerts, JG; Gras, J; Hoogsteden, H; Pouw, E; Pronk, T; Salomé, J; Schmitz, PI; Surmont, V; Tan, KY; van Klaveren, RJ; Vernhout, R, 2009) |
| "More than two-thirds of patients with gastric cancer present with metastatic disease and their curative options are limited." | 2.73 | Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. ( Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB, 2007) |
| " A phase II clinical trial of this combination using a continuous dosing schedule was carried out in patients with metastatic colorectal cancer." | 2.70 | Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer. ( Benson, AB; Catalano, P; Cornfeld, MJ; Graham, DL; Huang, J; Marsh, JC; O'Dwyer, PJ, 2002) |
| " The most appropriate dosing option appeared to be 400 mg x m(-2) per day of oral UFT for 14 consecutive days with 900 mg x m(-2) gemcitabine on days 8 and 15." | 2.70 | A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer. ( Asoh, H; Ichinose, Y; Semba, H; Seto, T; Yamamoto, H; Yoh, K, 2002) |
| "However, its activity in pancreatic cancer has not been fully evaluated." | 2.70 | Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer. ( Ikeda, M; Kuriyama, H; Okada, S; Okusaka, T; Ueno, H, 2002) |
| "In an ongoing trial of advanced breast cancer, preliminary results indicate that the combination of idarubicin, UFT, and leucovorin is active, with moderate, primarily hematologic toxicity." | 2.68 | Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast. ( Belón, J; Blanco, E; Espinosa, E; Feliu, J; Garcia Alfonso, P; Garcia Girón, C; Garrido, P; González Barón, M; Jara, C; Ruiz, A; Vincent, JM; Zamora, P, 1997) |
| " Based on those results, we conducted a pilot study to confirm the feasibility and antitumor effect of UFT in combination with cisplatin in patients with advanced non-small cell lung cancer (NSCLC)." | 2.68 | Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer. ( Koinumaru, S; Matsuda, T; Nakai, Y; Saitoh, J, 1997) |
| "According to the Japan Mammary Cancer Society's criteria of response, more than partial response was observed in 11 out of 32 cases (34." | 2.65 | [Clinical trial of UFT against disseminated breast cancer]. ( Harauchi, D; Itoh, S; Konishi, Y; Shinoto, M, 1984) |
| "The patient is alive and well without recurrence for more than 10years after lung resection." | 2.55 | [A Case of Recurrent Rectal Cancer with Adrenal and Lung Metastasis with More than Ten-Year Survival after Surgery]. ( Fuse, T; Katarao, Y; Kimura, Y; Shimizu, Y; Takemura, M; Tanaka, R; Uchiyama, K; Yamamoto, Y, 2017) |
| "UFT (tegafur and uracil) is an oral anticancer drug that has been developed in Japan." | 2.44 | UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction. ( Tanaka, F, 2007) |
| "The preoperative diagnosis was giant hepatocellular carcinoma (HCC) of the right hepatic anterior region, and extended anterior segmentectomy of the liver was performed." | 2.42 | [Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection]. ( Hanazaki, K; Kawasaki, S; Kobayashi, A; Matsushita, A; Misawa, R; Miwa, S; Miyagawa, S; Nakagawa, K; Nakata, T; Noike, T; Nomura, K, 2003) |
| "Tegafur/uracil (UFT) is an oral fluorinated pyrimidine composed of a combination of uracil and tegafur in a 4:1 molar ratio." | 2.40 | The role of tegafur/uracil in pulmonary malignancy. ( Langer, CJ, 1999) |
| "Tegafur acts as a prodrug of 5-fluorouracil (5-FU), being slowly metabolized by cytochrome P450 to 5-FU." | 2.40 | UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. ( Benner, SE; Canetta, R; Hoff, PM; Pazdur, R, 1998) |
| " The prevalence of adverse events did not differ significantly between the groups, and no severe adverse events occurred." | 1.91 | Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy. ( Doi, T; Funakoshi, Y; Hojo, W; Hokka, D; Maniwa, Y; Minami, H; Mitsui, S; Nishikubo, M; Ohji, G; Sakai, H; Tanaka, Y; Yakushijin, K, 2023) |
| "The possibility of interstitial pneumonitis should always be considered when a patient develops a fever and respiratory disorder during treatment containing TAS-102." | 1.48 | [A Case of Interstitial Pneumonitis Induced by TAS-102 for Liver and Lung Metastasis of Colorectal Cancer]. ( Hiramatsu, M; Imai, Y; Kobayashi, T; Kono, E; Sakane, J; Suzuki, Y; Tsunematsu, I, 2018) |
| "Zoledronic acid was also administered." | 1.40 | [A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival]. ( Abiko, M; Harada, M; Sato, T; Shiono, S; Takanashi, I, 2014) |
| "Herein, we report a bladder cancer case with multiple metastases which were controlled by low-dose UFT." | 1.37 | [A case of marked efficacy of low-dose UFT against metastatic bladder cancer]. ( Arai, Y; Ito, A; Kuwahara, M; Nakano, O; Satoh, M, 2011) |
| "Abdominoperineal resection+D3 of rectal cancer was performed, followed by chemotherapy with UFT for 28 days, and then partial resection of liver." | 1.37 | [A case of synchronous hepatic and multiple pulmonary metastases from rectal cancer responding completely to UFT therapy after resection of primary and hepatic lesions]. ( Doi, F; Ishikawa, N; Kohro, T; Kusumoto, C; Kusumoto, M; Matsumoto, T; Toyoda, S, 2011) |
| "The pathological diagnosis was renal cell carcinoma, clear cell type, grade 1, pT3bNxMx stage III." | 1.36 | [Tegafur-uracil markedly reduced pulmonary metastasis from renal cell carcinoma refractory to sorafenib, interferon and interleukin 2]. ( Homma, Y; Kaneko, T; Matsushima, H; Morimoto, H; Tsuzaka, Y, 2010) |
| "A 78-year-old male with sigmoid colon cancer underwent sigmoidectomy." | 1.35 | [A patient in whom oral UFT/Leucovorin therapy proved markedly effective for lung metastasis after surgery for colon cancer]. ( Abe, K; Itoh, K; Kamiizumi, Y; Kawamura, N; Nakajima, Y; Okamura, M; Yokoyama, R, 2008) |
| "She underwent radical resection for sigmoid colon cancer in 1998 and right lobectomy of the liver for metastatic liver tumor in 2001." | 1.34 | [A long-term surviving patient with unresectable lung metastasis from colon cancer treated with intravenous administration of activated autologous lymphocytes and low-dose chemotherapy--a case report]. ( Fujimoto, T; Kuhara, K; Matsumoto, A; Ogawa, K; Osawa, G; Otani, T; Shimakawa, T; Umehara, A; Yokomizo, H; Yoshimatsu, K, 2007) |
| "Uracil/tegafur was stopped in December 10, 2005, and docetaxel (taxotere) 50mg/m2 was given in December 12, 2005." | 1.34 | [Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer]. ( Bandoh, S; Kanaji, N, 2007) |
| "She had a history of superficial bladder tumors which were treated with transurethral resection (TURBT)." | 1.34 | [Superficial bladder cancer with lung metastasis without local invasion: a case report]. ( Ao, T; Baba, S; Hirayama, T; Irie, A; Iwabuchi, K; Iwamura, M; Kudoh, O; Matsumoto, K; Uchida, T, 2007) |
| "Two metastatic colonic cancer patients were successfully treated by the combination therapy of UFT plus oral Leucovorin (UFT/LV)." | 1.33 | [Two metastatic colonic cancer patients successfully treated by combination therapy of tegafur/uracil (UFT) and oral Leucovorin]. ( Ando, T; Goto, H; Ina, K; Inagaki, J; Ito, A; Kataoka, T; Kato, H; Nagao, S; Niwa, Y; Ohkita, T, 2006) |
| "A 54-year-old woman who had ascending colon cancer with multiple liver and lung metastases underwent rt." | 1.33 | [A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11]. ( Fujii, Y; Kobayashi, T; Kuga, T; Matsuoka, T; Morikage, N; Nakayama, T, 2005) |
| "The data on 307 patients with colorectal cancer at stage II or III, who underwent potentially curative resection with lymphadenectomy, were reviewed." | 1.33 | The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer. ( Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Ogo, S; Ohkita, A; Ozasa, H; Sasatomi, T; Shirouzu, K, 2006) |
| " 5-FU serum concentrations were higher at night time and the peak concentration of 5-FU was obtained at 3 a." | 1.33 | [Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report]. ( Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N, 2005) |
| "We report a rectal cancer case with liver and lung metastases treated successfully with this protocol." | 1.32 | [A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT]. ( Ebuchi, M; Hasegawa, K; Kato, K; Maruyama, M; Nagahama, T; Shinoura, H; Takashima, I, 2003) |
| "Human colon cancer cells (KM12SM) were injected into the cecal wall of the nude rats." | 1.31 | [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats]. ( Akagi, Y; Kobayashi, H; Matono, K; Miyagi, Y; Nakagawa, M; Nozoe, Y; Ogata, Y; Sasatomi, T; Shirouzu, K, 2001) |
| "The extent of lymphatic metastasis is the most important factor in the prognosis for non-small cell lung cancer (NSCLC)." | 1.31 | Suppression of mediastinal metastasis by uracil-tegafur or cis-diamminedichloroplatinum(II) using a lymphogenous metastatic model in a human lung cancer cell line. ( Fujino, H; Ishikura, H; Kinoshita, H; Kondo, K; Miyoshi, T; Monden, Y; Takahashi, Y, 2001) |
| "To evaluate the antitumor efficacy against metastatic breast cancer of fluoropyrimidines alone and combined with other chemotherapeutic agents, we developed a murine model of breast cancer metastatic to the lung by orthotopically implanting MDA-MB-435S breast tumors into mice." | 1.31 | [Antimetastatic and antitumor effects of fluoropyrimidines alone and combined with taxanes in a murine model of breast cancer metastatic to the lung]. ( Fujioka, A; Fukushima, M; Nakagawa, F; Nukatsuka, M; Ohshimo, H, 2002) |
| "We treated a patient with unresectable rectal cancer with multiple liver, pulmonary and lymph node metastases that responded remarkably to pharmacokinetic modulating chemotherapy (PMC)." | 1.31 | [A case of unresectable rectal cancer with liver and pulmonary metastases that responded remarkably to pharmacokinetic modulating chemotherapy]. ( Chiba, M; Hayashi, K; Inaba, Y; Kamio, Y; Koyama, M; Ohe, S; Watabe, S, 2002) |
| "However, the sensitivity to the micrometastases was high." | 1.31 | Experimental postoperative adjuvant chemotherapy by UFT using primary tumor amputation model. ( Fujioka, A; Fukushima, M; Nakano, K; Okabe, H; Saito, H; Sato, K; Takechi, T; Takeda, S; Uchida, J; Unemi, N, 2000) |
| " In the second and third courses of the chemotherapy, CBDCA and TXT were administered in the same dosage as in the initial course, but with the oral administration of UFT (600 mg/day)." | 1.31 | [A case of epithelial cancer of the alveoli which responded favorably to the additional administration of UFT for refractory cancer after administration of carboplatin and docetaxel]. ( Kuwahara, M; Motohiro, A; Takahashi, N; Tsukamoto, S; Ueda, H, 2000) |
| "Ultrasound and CT scan showed that the hepatocellular carcinoma and lung metastatic foci had disappeared completely." | 1.31 | [Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)]. ( Haseme, E; Kikuchi, K; Ohnishi, Y; Shohkei, O, 2001) |
| "Multiple liver and lung metastasis of breast cancer were diagnosed because of high CA 15/3 serum levels and normal gastrointestinal study." | 1.30 | [Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report]. ( Hoshino, K; Ikeda, H; Koyama, T; Morishita, Y; Nakamura, M, 1999) |
| "A 56-year-old male had suffered from hepatocellular carcinoma treated by operation, PHoT and TAE since 1994." | 1.30 | [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis]. ( Ando, A; Asano, N; Bamba, T; Fujiyama, Y; Fukano, M; Inoue, T; Ito, A; Koyama, S; Kubo, M; Sasaki, M; Sato, J; Tsujikawa, T; Yoshioka, U, 1998) |
| "A 65-year-old male with hepatocellular carcinoma was admitted to our hospital." | 1.29 | [A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT]. ( Fujiyama, S; Hashiguchi, O; Hayashida, T; Ikebe, M; Noumaru, S; Sato, K; Sato, T; Shibata, J, 1994) |
| "This is a rare case of renal cell carcinoma with local recurrence and lung metastasis successfully treated with UFT." | 1.28 | [A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT]. ( Matsuda, M; Taguchi, H; Takaoka, K, 1992) |
| " Since she complained of olfactory anesthesia at 2 months of treatment, the dosage of UFT was reduced to 2 capsules daily and the drug was withdrawn after another 2 months of treatment." | 1.28 | [Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report]. ( Fukuoka, H; Nomura, S; Ogawa, T; Sakanishi, S; Takeda, M, 1991) |
| "He was diagnosed as having right renal cell carcinoma which had metastasized to the lung." | 1.28 | [A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only]. ( Kayama, T; Ogawa, A; Sakurai, Y; Sato, K; Wada, T, 1990) |
| "Eighty patients of renal cell carcinoma were treated during the period." | 1.28 | [Therapy on pulmonary metastasis of renal cell carcinoma]. ( Akimoto, M; Hara, M; Hasegawa, J; Kawamura, N, 1990) |
| "We investigated the effective timing of UFT administration combined with surgical operation for inhibiting pulmonary metastasis of spontaneously developed mammary carcinoma (SST-2) which produces 100% pulmonary metastasis in syngeneic rats after s." | 1.28 | [Timing of UFT administration combined with surgical operation in pulmonary metastasis of rat mammary carcinoma]. ( Hamada, J; Hosokawa, M; Kobayashi, H; Li, XB; Takeichi, N, 1989) |
| "Primary hepatocellular carcinoma complicated by compensatory cirrhosis accompanying pulmonary metastasis was diagnosed from blood biochemistry tests, a high AFP value (390,000 ng/ml) and angiogram findings." | 1.27 | [Almost complete disappearance of metastatic pulmonary tumor and reduction of the main hepatic mass in a case of hepatocellular carcinoma treated with UFT]. ( Hayashi, K; Hidaka, Y; Kitamura, T; Maruyama, T; Nakamura, H; Nakatsuru, K; Shigehira, M; Tsuda, K, 1987) |
| " 5'-DFUR was less toxic to immune organs and the functions than those by other fluorinated pyrimidines." | 1.27 | [Antitumor activity and toxicity to the immune system and intestine, of the fluorinated pyrimidines FUra, 5'-DFUR, tegafur and UFT]. ( Fujimoto, K; Ishitsuka, H; Matsuura, N; Miwa, M; Ninomiya, Y; Ryu, M, 1988) |
| "Lymph node metastasis was not related to the concentration of 5-FU in the lymph nodes." | 1.27 | [Serum and tissue concentrations of UFT in patients with lung cancer]. ( Aota, M; Daitoh, N; Jinno, K; Nakayama, S; Yokomise, H, 1986) |
| "A case of relapsed gastric cancer postoperatively presenting obstructive jaundice due to metastases in the hepatic portal and periaortic lymph nodes and multiple lung metastases was given OK-432 continuously i." | 1.27 | [A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system]. ( Kawahara, M; Matsuo, T; Nagamatsu, Y; Nakarai, I; Shinoda, A, 1986) |
| "There were PR cases in hepatoma and breast cancer also." | 1.27 | [Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group]. ( Futatsuki, K; Kamano, T; Komita, T; Watanabe, H, 1987) |
| "A case of multiple lung metastasis of renal cell carcinoma in which complete remission was obtained with administration of UFT (Tegafur + Uracil) is reported." | 1.27 | [Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy]. ( Fukushima, S; Sakuramoto, T; Sugawara, T, 1987) |
| "A rare case of metastatic renal cell carcinoma which represented complete remission by chemotherapy and surgical treatment is presented." | 1.27 | [Complete remission of advanced renal cell carcinoma by chemotherapy and surgical treatment: a case report]. ( Fukuoka, H; Goto, A; Kitamura, H; Murai, T, 1987) |
| "Fifteen cases with advanced cancer were treated with UFD-1 (mixture of FD-1 and uracil under molar ratio of 1: 20) in a daily dose of 300 mg of FD-1." | 1.26 | [Clinical experiences with UFD-1]. ( Furue, H, 1982) |
| " The 5-fluoro-uracil was given intravenously at a relatively nontoxic dosage level." | 1.24 | The potentiation of radiation effects with 5-fluoro-uracil. ( FOYE, LV; HALL, B; ROTH, M; WILLETT, FM, 1960) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (15.16) | 18.7374 |
| 1990's | 58 (23.77) | 18.2507 |
| 2000's | 103 (42.21) | 29.6817 |
| 2010's | 37 (15.16) | 24.3611 |
| 2020's | 9 (3.69) | 2.80 |
| Authors | Studies |
|---|---|
| Li, XY | 1 |
| Zhang, TJ | 1 |
| Kamara, MO | 1 |
| Lu, GQ | 1 |
| Xu, HL | 1 |
| Wang, DP | 1 |
| Meng, FH | 1 |
| Yamaguchi, M | 2 |
| Tada, H | 3 |
| Mitsudomi, T | 1 |
| Seto, T | 4 |
| Yokoi, K | 1 |
| Katakami, N | 1 |
| Nakagawa, K | 4 |
| Oda, M | 3 |
| Ohta, M | 8 |
| Sawa, T | 1 |
| Yamashita, M | 5 |
| Iked, N | 1 |
| Saka, H | 1 |
| Higashiyama, M | 1 |
| Nomori, H | 1 |
| Semba, H | 6 |
| Negoro, S | 1 |
| Chiba, Y | 1 |
| Shimokawa, M | 1 |
| Fukuoka, M | 1 |
| Nakanishi, Y | 2 |
| Noro, R | 1 |
| Honda, K | 1 |
| Nagashima, K | 1 |
| Motoi, N | 1 |
| Kunugi, S | 1 |
| Matsubayashi, J | 1 |
| Takeuchi, S | 1 |
| Shiraishi, H | 1 |
| Okano, T | 1 |
| Kashiro, A | 1 |
| Meng, X | 1 |
| Yoshida, Y | 2 |
| Watanabe, S | 2 |
| Usuda, J | 1 |
| Inoue, T | 2 |
| Wilber, H | 1 |
| Ikeda, N | 1 |
| Seike, M | 2 |
| Gemma, A | 1 |
| Kubota, K | 1 |
| Okamoto, K | 1 |
| Kaku, R | 1 |
| Oshio, Y | 1 |
| Hanaoka, J | 1 |
| Yonaga, K | 1 |
| Yamada, T | 2 |
| Matsuda, A | 2 |
| Sonoda, H | 1 |
| Shinji, S | 1 |
| Ohta, R | 1 |
| Iwai, T | 1 |
| Takeda, K | 1 |
| Ueda, K | 1 |
| Kuriyama, S | 1 |
| Miyasaka, T | 1 |
| Yoshida, H | 1 |
| Miyata, R | 1 |
| Hamaji, M | 1 |
| Nakakura, A | 1 |
| Morita, S | 2 |
| Shimazu, Y | 1 |
| Ishikawa, M | 1 |
| Kayawake, H | 1 |
| Menju, T | 1 |
| Sakaguchi, Y | 1 |
| Sonobe, M | 1 |
| Takahashi, M | 1 |
| Aoyama, A | 1 |
| Sumitomo, R | 1 |
| Huang, CL | 1 |
| Kono, T | 1 |
| Miyahara, R | 7 |
| Matsumoto, A | 3 |
| Katakura, H | 1 |
| Fukada, T | 1 |
| Sakai, H | 2 |
| Kobayashi, M | 2 |
| Okumura, N | 2 |
| Date, N | 1 |
| Fujinaga, T | 1 |
| Miyamoto, E | 1 |
| Nakagawa, T | 3 |
| Date, H | 3 |
| Nishikubo, M | 1 |
| Tanaka, Y | 3 |
| Mitsui, S | 1 |
| Doi, T | 1 |
| Hokka, D | 1 |
| Hojo, W | 1 |
| Funakoshi, Y | 1 |
| Yakushijin, K | 1 |
| Ohji, G | 1 |
| Minami, H | 1 |
| Maniwa, Y | 1 |
| Liang, SK | 1 |
| Wu, CW | 1 |
| Chang, CI | 1 |
| Keng, LT | 1 |
| Lee, MR | 1 |
| Wang, JY | 1 |
| Ko, JC | 1 |
| Liao, WY | 1 |
| Chen, KY | 1 |
| Ho, CC | 1 |
| Shih, JY | 1 |
| Yu, CJ | 1 |
| Tsuchiya, T | 2 |
| Kamohara, R | 2 |
| Muraoka, M | 2 |
| Nagayasu, T | 1 |
| Saeki, S | 1 |
| Takenoyama, M | 1 |
| Suzuki, M | 2 |
| Inada, K | 2 |
| Tokunaga, S | 1 |
| Hayashi, T | 1 |
| Urabe, S | 2 |
| Koga, T | 2 |
| Akamine, S | 2 |
| Sugio, K | 1 |
| Kawamoto, N | 1 |
| Okita, R | 2 |
| Hayashi, M | 1 |
| Okada, M | 1 |
| Inokawa, H | 1 |
| Tsuboi, M | 4 |
| Hamada, C | 2 |
| Kato, H | 5 |
| Sawada, S | 2 |
| Sugimoto, R | 1 |
| Ueno, T | 1 |
| Uchiyama, K | 1 |
| Katarao, Y | 1 |
| Kimura, Y | 1 |
| Tanaka, R | 1 |
| Fuse, T | 1 |
| Takemura, M | 1 |
| Yamamoto, Y | 2 |
| Shimizu, Y | 1 |
| Rossi, A | 1 |
| Novello, S | 1 |
| Unseld, M | 1 |
| Drimmel, M | 1 |
| Siebenhüner, A | 1 |
| Gleiss, A | 1 |
| Bianconi, D | 1 |
| Kieler, M | 1 |
| Scheithauer, W | 1 |
| Winder, T | 1 |
| Prager, GW | 1 |
| Kashiwabara, K | 1 |
| Fujii, S | 3 |
| Tsumura, S | 1 |
| Kono, E | 1 |
| Hiramatsu, M | 1 |
| Kobayashi, T | 2 |
| Tsunematsu, I | 1 |
| Imai, Y | 1 |
| Sakane, J | 1 |
| Suzuki, Y | 1 |
| Soh, J | 2 |
| Toyooka, S | 3 |
| Nakamura, H | 2 |
| Nakata, M | 2 |
| Sakamoto, J | 1 |
| Aoe, M | 1 |
| Hotta, K | 2 |
| Minomo, S | 1 |
| Asami, K | 1 |
| Okishio, K | 1 |
| Kawaguchi, T | 2 |
| Fujita, Y | 1 |
| Takata, S | 1 |
| Tamura, A | 1 |
| Saitou, R | 1 |
| Atagi, S | 1 |
| Do, H | 1 |
| Wong, SQ | 1 |
| Li, J | 1 |
| Dobrovic, A | 1 |
| Tanabe, K | 1 |
| Taura, K | 1 |
| Hatano, E | 1 |
| Koyama, Y | 1 |
| Takada, Y | 1 |
| Uemoto, S | 1 |
| Wang, LW | 1 |
| Hsiao, CF | 1 |
| Chen, WT | 1 |
| Lee, HH | 1 |
| Lin, TC | 1 |
| Chen, HC | 1 |
| Chen, HH | 1 |
| Chien, CR | 1 |
| Lin, TY | 1 |
| Liu, TW | 1 |
| Shiono, S | 1 |
| Harada, M | 1 |
| Abiko, M | 1 |
| Sato, T | 4 |
| Takanashi, I | 1 |
| Paone, A | 1 |
| Marani, M | 1 |
| Fiascarelli, A | 1 |
| Rinaldo, S | 1 |
| Giardina, G | 1 |
| Contestabile, R | 1 |
| Paiardini, A | 1 |
| Cutruzzolà, F | 1 |
| Hishida, T | 1 |
| Shukuya, T | 1 |
| Takamochi, K | 1 |
| Sakurai, H | 1 |
| Yoh, K | 2 |
| Ohashi, Y | 1 |
| Kunitoh, H | 1 |
| Koyama, T | 2 |
| Funato, Y | 1 |
| Yamaguchi, Y | 2 |
| Ito, K | 2 |
| Shiraishi, T | 1 |
| Moriya, T | 1 |
| Ueno, H | 3 |
| Shinto, E | 1 |
| Kajiwara, Y | 1 |
| Sueyama, T | 1 |
| Watanabe, T | 2 |
| Yamadera, M | 1 |
| Yamamoto, J | 1 |
| Hase, K | 1 |
| Hasegawa, J | 2 |
| Noura, S | 1 |
| Hirota, M | 1 |
| Matsumura, T | 1 |
| Yasuyama, A | 1 |
| Takata, A | 1 |
| Koga, C | 1 |
| Murakami, M | 1 |
| Kameda, C | 1 |
| Oda, N | 1 |
| Kawabata, R | 1 |
| Morishima, H | 1 |
| Shimizu, J | 1 |
| Matsunami, N | 1 |
| Yamanaka, T | 1 |
| Nakano, M | 1 |
| Ota, M | 1 |
| Maruyama, R | 2 |
| Okamoto, T | 4 |
| Wataya, H | 1 |
| Uematsu, K | 1 |
| Seki, N | 1 |
| Eguchi, K | 2 |
| Ichinose, Y | 15 |
| Okamura, M | 1 |
| Kamiizumi, Y | 1 |
| Kawamura, N | 2 |
| Yokoyama, R | 1 |
| Itoh, K | 2 |
| Abe, K | 2 |
| Nakajima, Y | 1 |
| Nishimura, N | 1 |
| Sugiura, R | 1 |
| Ueda, H | 3 |
| Ono, H | 1 |
| Horinouchi, H | 1 |
| Uchiyama, N | 1 |
| Chohnabayashi, N | 1 |
| Hoshikawa, K | 1 |
| Aoki, K | 1 |
| Noda, H | 1 |
| Oyama, K | 1 |
| Nitta, H | 1 |
| Wakabayashi, G | 1 |
| Surmont, V | 1 |
| Aerts, JG | 1 |
| Pouw, E | 1 |
| Tan, KY | 1 |
| Vernhout, R | 1 |
| Gras, J | 1 |
| Salomé, J | 1 |
| Pronk, T | 1 |
| Schmitz, PI | 1 |
| Hoogsteden, H | 1 |
| van Klaveren, RJ | 1 |
| Tokunaga, Y | 1 |
| Sasaki, H | 1 |
| Saito, T | 1 |
| Fujimura, S | 2 |
| Kodama, K | 2 |
| Imaizumi, M | 2 |
| Wada, H | 18 |
| Suehisa, H | 2 |
| Tanaka, F | 14 |
| Fukushima, M | 8 |
| Komori, E | 1 |
| Suehiro, H | 1 |
| Ogino, A | 1 |
| Nogami, H | 1 |
| Segawa, Y | 1 |
| Shinkai, T | 2 |
| Miyano, M | 1 |
| Kurai, O | 1 |
| Hiramatsu, S | 1 |
| Yamasaki, T | 1 |
| Sasaki, E | 1 |
| Adachi, K | 1 |
| Oka, H | 1 |
| Morimoto, H | 1 |
| Tsuzaka, Y | 1 |
| Kaneko, T | 1 |
| Matsushima, H | 1 |
| Homma, Y | 1 |
| Goto, T | 1 |
| Maeshima, A | 1 |
| Oyamada, Y | 1 |
| Wakaki, M | 1 |
| Hamaguchi, R | 1 |
| Kato, R | 1 |
| Suzuki, E | 1 |
| Furuse, J | 1 |
| Ikeda, M | 2 |
| Ishii, H | 2 |
| Okusaka, T | 2 |
| Nakachi, K | 1 |
| Mitsunaga, S | 1 |
| Morizane, C | 1 |
| Yoshioka, S | 2 |
| Wakatsuki, K | 1 |
| Kataoka, M | 1 |
| Tonooka, T | 1 |
| Miyazawa, K | 1 |
| Suzuki, D | 1 |
| Furukawa, A | 1 |
| Oeda, Y | 1 |
| Kusumoto, M | 1 |
| Toyoda, S | 1 |
| Matsumoto, T | 1 |
| Ishikawa, N | 1 |
| Kusumoto, C | 1 |
| Kohro, T | 1 |
| Doi, F | 1 |
| Chen, YM | 2 |
| Fan, WC | 1 |
| Tsai, CM | 2 |
| Liu, SH | 1 |
| Shih, JF | 2 |
| Chou, TY | 1 |
| Wu, CH | 1 |
| Chou, KT | 2 |
| Lee, YC | 1 |
| Perng, RP | 2 |
| Whang-Peng, J | 2 |
| Takagi, K | 1 |
| Kawamoto, K | 1 |
| Ikeda, H | 2 |
| Itoh, T | 1 |
| Satoh, M | 1 |
| Nakano, O | 1 |
| Kuwahara, M | 3 |
| Ito, A | 3 |
| Arai, Y | 1 |
| Endo, M | 1 |
| Aoki, T | 3 |
| Tsuchida, A | 1 |
| Nagahiro, I | 1 |
| Miyamoto, M | 1 |
| Sugiyama, H | 1 |
| Kawai, T | 1 |
| Toda, K | 1 |
| Nobuhisa, T | 1 |
| Endou, Y | 1 |
| Matsumoto, Y | 1 |
| Watanabe, N | 1 |
| Kai, K | 1 |
| Satou, S | 1 |
| Baek, JH | 2 |
| Kim, H | 2 |
| Ahn, JJ | 2 |
| Jegal, Y | 2 |
| Seo, KW | 2 |
| Ra, SW | 1 |
| Park, CR | 2 |
| Jung, JP | 2 |
| Kim, JW | 2 |
| Lee, YJ | 1 |
| Cha, HJ | 2 |
| Kwon, WJ | 2 |
| Noh, YJ | 2 |
| Oh, S | 1 |
| Park, JH | 2 |
| Min, YJ | 2 |
| Sakamoto, Y | 1 |
| Murata, A | 1 |
| Koyama, M | 2 |
| Morohashi, H | 1 |
| Tsutsumi, S | 1 |
| Yonaiyama, S | 1 |
| Morita, T | 2 |
| Hakamada, K | 1 |
| Takada, A | 1 |
| Kawahara, M | 2 |
| Kobayashi, H | 4 |
| Takino, Y | 1 |
| Kodama, T | 1 |
| Sugishita, T | 1 |
| Ohno, Y | 1 |
| Oka, T | 1 |
| Tsukamoto, F | 1 |
| Francois, E | 1 |
| Smith, D | 1 |
| Dahan, L | 1 |
| Michel, C | 1 |
| Perrier, H | 1 |
| Mari, V | 1 |
| Seitz, JF | 1 |
| Follana, P | 1 |
| Evesque, L | 1 |
| Chamorey, E | 1 |
| Kuwata, T | 1 |
| Iwata, T | 1 |
| Iwanami, T | 1 |
| Kawaguchi, M | 1 |
| Takata, T | 1 |
| Matsuoka, K | 1 |
| Otake, Y | 4 |
| Yanagihara, K | 4 |
| Fukushimab, M | 1 |
| Inaba, Y | 1 |
| Watabe, S | 1 |
| Hayashi, K | 3 |
| Ohe, S | 1 |
| Kamio, Y | 1 |
| Chiba, M | 1 |
| Teruya, T | 1 |
| Ikeda, J | 2 |
| Ushijima, C | 3 |
| Asoh, H | 7 |
| Fukuyama, Y | 3 |
| Ojima, E | 1 |
| Miki, C | 1 |
| Hatada, T | 1 |
| Inoue, Y | 3 |
| Mohri, T | 1 |
| Azuma, T | 1 |
| Kusunoki, M | 1 |
| Marsh, JC | 1 |
| Catalano, P | 1 |
| Huang, J | 1 |
| Graham, DL | 1 |
| Cornfeld, MJ | 1 |
| O'Dwyer, PJ | 1 |
| Benson, AB | 1 |
| Hanaoka, N | 1 |
| Sadahiro, S | 1 |
| Suzuki, T | 1 |
| Ishikawa, K | 2 |
| Maeda, Y | 1 |
| Saguchi, T | 1 |
| Yasuda, S | 1 |
| Makuuchi, H | 1 |
| Murayama, C | 1 |
| Yamamoto, T | 3 |
| Hattori, K | 1 |
| Kohchi, Y | 1 |
| Oikawa, N | 1 |
| Suda, H | 1 |
| Ura, M | 1 |
| Ishikawa, T | 1 |
| Miwa, M | 3 |
| Endoh, M | 1 |
| Eda, H | 2 |
| Tanimura, H | 1 |
| Kawashima, A | 1 |
| Horii, I | 1 |
| Ishitsuka, H | 3 |
| Shimma, N | 1 |
| Endo, C | 1 |
| Saito, Y | 2 |
| Iwanami, H | 1 |
| Tsushima, T | 2 |
| Imai, T | 1 |
| Kawamura, M | 1 |
| Kondo, T | 1 |
| Koike, K | 1 |
| Handa, M | 1 |
| Kanno, R | 1 |
| Kawasaki, Y | 2 |
| Koshohbu, T | 1 |
| Nakatani, S | 1 |
| Matsumoto, S | 1 |
| Yasuda, K | 1 |
| Hitsuda, Y | 1 |
| Shimizu, E | 2 |
| Nishimura, R | 1 |
| Nagao, K | 1 |
| Miyayama, H | 1 |
| Okazaki, S | 2 |
| Fujimura, Y | 2 |
| Yano, T | 6 |
| Nomiyama, H | 1 |
| Hidaka, H | 1 |
| Motoyama, H | 1 |
| Funakoshi, K | 1 |
| Akiyama, N | 1 |
| Inayoshi, J | 1 |
| Kozakai, I | 1 |
| Arai, F | 1 |
| Kato, T | 1 |
| Takii, Y | 1 |
| Ohta, T | 1 |
| FOYE, LV | 2 |
| WILLETT, FM | 2 |
| HALL, B | 1 |
| ROTH, M | 2 |
| HALL, BE | 1 |
| ZIMMERMAN, M | 1 |
| SEIDENBERG, J | 1 |
| HOSLEY, HF | 1 |
| MARANGOUDAKIS, S | 1 |
| ROSS, CA | 1 |
| MURPHY, WT | 1 |
| HOLLAND, JF | 1 |
| Matsushita, A | 1 |
| Hanazaki, K | 1 |
| Noike, T | 1 |
| Misawa, R | 1 |
| Nakata, T | 1 |
| Nomura, K | 1 |
| Kobayashi, A | 1 |
| Miwa, S | 1 |
| Miyagawa, S | 1 |
| Kawasaki, S | 1 |
| Hasegawa, K | 2 |
| Maruyama, M | 2 |
| Nagahama, T | 1 |
| Takashima, I | 1 |
| Shinoura, H | 1 |
| Kato, K | 1 |
| Ebuchi, M | 1 |
| Okamoto, J | 1 |
| Sakai, M | 1 |
| Sakada, T | 1 |
| Motohiro, A | 3 |
| Hata, E | 1 |
| Tsubota, N | 2 |
| Watanabe, Y | 4 |
| Hamajima, N | 1 |
| Diasio, RB | 1 |
| Wei, J | 1 |
| Blum, S | 1 |
| Unger, M | 1 |
| Jarmy, G | 1 |
| Lamparter, M | 1 |
| Geishauser, A | 1 |
| Vlastos, GA | 1 |
| Chan, G | 1 |
| Fischer, KD | 1 |
| Rattat, D | 1 |
| Debatin, KM | 1 |
| Hatzopoulos, AK | 1 |
| Beltinger, C | 1 |
| Nakai, Y | 2 |
| Kudoh, S | 4 |
| Yoshida, S | 2 |
| Nukiwa, T | 1 |
| Yamamoto, H | 4 |
| Yamane, Y | 1 |
| Niitani, H | 3 |
| Altundag, O | 1 |
| Altundag, K | 1 |
| Gunduz, M | 1 |
| Graziano, F | 1 |
| Morio, A | 1 |
| Miyamoto, H | 1 |
| Izumi, H | 1 |
| Futagawa, T | 1 |
| Oh, T | 1 |
| Yamazaki, A | 1 |
| Konno, H | 1 |
| Nakamura, M | 3 |
| Nagano, H | 3 |
| Sakon, M | 1 |
| Kondo, M | 1 |
| Ota, H | 1 |
| Damdinsuren, B | 2 |
| Yang, Y | 1 |
| Marubashi, S | 2 |
| Miyamoto, A | 2 |
| Dono, K | 2 |
| Umeshita, K | 2 |
| Nakamori, S | 1 |
| Monden, M | 2 |
| Akagi, Y | 2 |
| Hashimoto, Y | 1 |
| Takiyama, W | 1 |
| Mukaida, H | 1 |
| Murakami, Y | 1 |
| Nakagawa, M | 2 |
| Takao, M | 1 |
| Teramoto, N | 1 |
| Bessho, A | 1 |
| Mogami, H | 1 |
| Muneoka, K | 3 |
| Shirai, Y | 3 |
| Yokoyama, N | 3 |
| Wakai, T | 3 |
| Hatakeyama, K | 3 |
| Ishikawa, S | 2 |
| Kimura, M | 1 |
| Inoue, M | 1 |
| Morisaki, T | 1 |
| Kaneda, H | 1 |
| Kume, S | 1 |
| Matsushita, H | 1 |
| Horino, K | 1 |
| Nishimura, T | 2 |
| Arima, T | 1 |
| Uemura, K | 1 |
| Takechi, T | 3 |
| Okabe, H | 2 |
| Ikeda, K | 1 |
| Fujioka, A | 3 |
| Nakagawa, F | 2 |
| Ohshimo, H | 2 |
| Kitazato, K | 1 |
| Wilhelm, L | 1 |
| Kolesar, JM | 1 |
| Okumura, S | 1 |
| Endo, S | 1 |
| Saito, N | 2 |
| Hasegawa, T | 1 |
| Sato, Y | 1 |
| Sohara, Y | 1 |
| Ogata, Y | 2 |
| Matono, K | 2 |
| Sasatomi, T | 2 |
| Ishibashi, N | 1 |
| Ohkita, A | 1 |
| Mizobe, T | 1 |
| Ogo, S | 1 |
| Ikeda, S | 2 |
| Ozasa, H | 1 |
| Shirouzu, K | 2 |
| Araki, J | 1 |
| Tamanoi, M | 1 |
| Iwamoto, N | 1 |
| Stewart, L | 1 |
| Burdett, S | 1 |
| Matsuoka, T | 1 |
| Morikage, N | 1 |
| Kuga, T | 1 |
| Nakayama, T | 1 |
| Fujii, Y | 1 |
| Pisters, KM | 1 |
| Fukasawa, M | 1 |
| Kitahama, S | 1 |
| Kitagawa, M | 1 |
| Yamamoto, S | 1 |
| Koneri, K | 1 |
| Kusanagi, H | 1 |
| Kuroki, M | 1 |
| Takeshi, A | 1 |
| Kano, N | 1 |
| Noda, T | 1 |
| Takeda, Y | 1 |
| Solomon, B | 1 |
| Mitchell, JD | 1 |
| Bunn, PA | 1 |
| Park, I | 1 |
| Chung, KY | 1 |
| Kim, KD | 1 |
| Kim, DJ | 1 |
| Iwatsuki, M | 1 |
| Kuramoto, M | 1 |
| Ishihara, K | 1 |
| Ikeshima, S | 1 |
| Hasuo, T | 1 |
| Sakata, J | 1 |
| Ishida, H | 1 |
| Akita, H | 1 |
| Nakaguchi, K | 1 |
| Kabuto, T | 1 |
| Nakano, J | 1 |
| Huang, C | 1 |
| Liu, D | 1 |
| Masuya, D | 1 |
| Nakashima, T | 1 |
| Yokomise, H | 2 |
| Ueno, M | 1 |
| Akashi, A | 1 |
| Yasumitsu, T | 1 |
| Iuchi, K | 1 |
| Taki, T | 1 |
| Ina, K | 1 |
| Kataoka, T | 1 |
| Ohkita, T | 1 |
| Nagao, S | 1 |
| Inagaki, J | 1 |
| Ando, T | 1 |
| Niwa, Y | 1 |
| Goto, H | 1 |
| Hanada, M | 1 |
| Noguchi, T | 1 |
| Yamaoka, T | 1 |
| Tsuji, K | 1 |
| Honda, S | 1 |
| Yamasaki, N | 1 |
| Hirayama, T | 1 |
| Matsumoto, K | 1 |
| Irie, A | 1 |
| Iwamura, M | 1 |
| Kudoh, O | 1 |
| Iwabuchi, K | 1 |
| Ao, T | 1 |
| Uchida, T | 1 |
| Baba, S | 1 |
| Idelevich, E | 1 |
| Karminsky, N | 1 |
| Dinerman, M | 1 |
| Katsenelson, RL | 1 |
| Zvi, NB | 1 |
| Baruch, NB | 1 |
| Biran, H | 1 |
| Man, S | 1 |
| Shani, A | 1 |
| Hanibuchi, M | 1 |
| Yano, S | 1 |
| Tomimoto, H | 1 |
| Sone, S | 2 |
| Kanaji, N | 2 |
| Bandoh, S | 2 |
| Seike, J | 1 |
| Yoshida, T | 1 |
| Honda, J | 1 |
| Miyoshi, T | 2 |
| Umemoto, A | 1 |
| Tangoku, A | 1 |
| Ohata, M | 1 |
| Ohori, M | 1 |
| Tokura, Y | 1 |
| Furukawa, T | 1 |
| Sato, H | 1 |
| Hoshi, K | 1 |
| Kanbara, T | 1 |
| Ikeda, Y | 2 |
| Namima, T | 1 |
| Ohnuma, T | 1 |
| Uchida, A | 1 |
| Fujiwara, Y | 2 |
| Matsuo, K | 1 |
| Ouchida, M | 1 |
| Takata, M | 1 |
| Kiura, K | 1 |
| Ono, Y | 1 |
| Hino, M | 1 |
| Ueda, Y | 1 |
| Kamizuru, R | 1 |
| Omata, M | 1 |
| Uehara, T | 3 |
| Soma, T | 1 |
| Ishida, T | 1 |
| Shin, SJ | 1 |
| Shin, JK | 1 |
| Jeong, AK | 1 |
| Takayama, K | 1 |
| Kawasaki, M | 1 |
| Ninomiya, K | 1 |
| Fujita, M | 3 |
| Watanabe, K | 2 |
| Kajiki, A | 1 |
| Iwami, F | 1 |
| Miyazaki, N | 1 |
| Izumi, M | 1 |
| Hara, N | 3 |
| Yoshimatsu, K | 1 |
| Yokomizo, H | 1 |
| Fujimoto, T | 1 |
| Otani, T | 1 |
| Osawa, G | 1 |
| Umehara, A | 1 |
| Kuhara, K | 1 |
| Shimakawa, T | 1 |
| Ogawa, K | 1 |
| Hosotaki, K | 1 |
| Tabira, Y | 1 |
| Shimamoto, M | 1 |
| Tamori, Y | 1 |
| Chu, MY | 1 |
| Naguib, FN | 1 |
| Iltzsch, MH | 1 |
| el Kouni, MH | 1 |
| Chu, SH | 1 |
| Cha, S | 1 |
| Calabresi, P | 1 |
| Itoh, S | 1 |
| Konishi, Y | 1 |
| Harauchi, D | 1 |
| Shinoto, M | 1 |
| Furue, H | 1 |
| Takanashi, N | 2 |
| Yokoyama, H | 4 |
| Tayama, K | 2 |
| Wang, YJ | 1 |
| Ho, YS | 1 |
| Lo, MJ | 1 |
| Lin, JK | 1 |
| Kinoshita, S | 1 |
| Matsuda, R | 1 |
| Takatsuki, H | 1 |
| Shimahara, Y | 1 |
| Kobayashi, N | 1 |
| Shibata, J | 3 |
| Hayashida, T | 1 |
| Ikebe, M | 1 |
| Sato, K | 3 |
| Noumaru, S | 1 |
| Fujiyama, S | 1 |
| Hashiguchi, O | 1 |
| Miyauchi, S | 1 |
| Imaoka, T | 1 |
| Utsunomiya, T | 1 |
| Kubo, M | 2 |
| Matsui, Y | 1 |
| Kinoshita, T | 1 |
| Akaogi, E | 1 |
| Mitsui, K | 1 |
| Onizuka, M | 1 |
| Morita, R | 1 |
| Ishibashi, O | 1 |
| Suga, M | 1 |
| Inagaki, M | 1 |
| Okazaki, H | 1 |
| Uchida, J | 3 |
| Satake, H | 1 |
| Saito, H | 3 |
| Nakano, K | 3 |
| Takeda, S | 3 |
| Unemi, N | 2 |
| Dan, A | 1 |
| Minakawa, N | 1 |
| Tregear, SJ | 1 |
| Sugimoto, Y | 1 |
| Sasaki, T | 1 |
| Hirata, K | 1 |
| Sasaki, K | 1 |
| Yamamitsu, S | 1 |
| Shirasaka, T | 1 |
| Miura, T | 1 |
| Matsuoka, Y | 1 |
| Fujita, F | 1 |
| Inaba, H | 1 |
| Taguchi, T | 5 |
| Sakaguchi, T | 1 |
| Watahiki, Y | 1 |
| Kosaka, A | 1 |
| Taniwaki, M | 1 |
| Kakusui, M | 1 |
| Imoto, M | 1 |
| Takashima, T | 1 |
| Misawa, S | 1 |
| Kashima, K | 1 |
| Bibby, MC | 2 |
| Double, JA | 2 |
| McCormick, JE | 2 |
| McElhinney, RS | 2 |
| Radacic, M | 2 |
| Pratesi, G | 2 |
| Dumont, P | 2 |
| Terachi, T | 1 |
| Okada, Y | 2 |
| Takeuchi, H | 1 |
| Yoshida, O | 1 |
| Feld, R | 1 |
| Hitomi, S | 5 |
| Teramatsu, T | 1 |
| Tsurumachi, T | 1 |
| Honda, I | 1 |
| Yamada, S | 1 |
| Jingu, K | 1 |
| Satomi, D | 1 |
| Hayashi, Y | 1 |
| Maehara, T | 1 |
| Morohoshi, T | 1 |
| Kubo, A | 1 |
| Amano, T | 1 |
| Imada, T | 1 |
| Ito, H | 1 |
| Fukuda, Y | 1 |
| Maruyama, A | 1 |
| Fujita, H | 1 |
| Yagihashi, N | 1 |
| Tsuge, T | 1 |
| Ishioka, T | 1 |
| Kudo, T | 1 |
| Kishibe, S | 1 |
| Machida, S | 1 |
| Kogawa, R | 1 |
| Takashima, K | 1 |
| Koie, H | 1 |
| Fujita, K | 1 |
| Kobayashi, K | 2 |
| Feliu, J | 1 |
| González Barón, M | 1 |
| Zamora, P | 1 |
| Garcia Alfonso, P | 1 |
| Garcia Girón, C | 1 |
| Blanco, E | 1 |
| Belón, J | 1 |
| Garrido, P | 1 |
| Jara, C | 1 |
| Ruiz, A | 1 |
| Vincent, JM | 1 |
| Espinosa, E | 1 |
| Tsukagoshi, S | 1 |
| Yoshimori, K | 1 |
| Morikawa, T | 1 |
| Kuba, M | 2 |
| Koinumaru, S | 1 |
| Matsuda, T | 1 |
| Saitoh, J | 1 |
| Miyagi, T | 1 |
| Fuse, H | 1 |
| Uchibayashi, T | 1 |
| Namiki, M | 1 |
| Mizukami, Y | 1 |
| Asano, N | 1 |
| Fukano, M | 1 |
| Sato, J | 1 |
| Tsujikawa, T | 1 |
| Ando, A | 1 |
| Sasaki, M | 1 |
| Yoshioka, U | 1 |
| Koyama, S | 1 |
| Fujiyama, Y | 1 |
| Bamba, T | 1 |
| Kume, M | 1 |
| Ogoshi, S | 1 |
| Hisa, N | 1 |
| Andoh, M | 1 |
| Sakonji, M | 1 |
| Tsuboi, E | 1 |
| Ito, T | 1 |
| Yamada, M | 1 |
| Tanemura, H | 1 |
| Oshita, H | 1 |
| Asano, M | 1 |
| Saji, S | 1 |
| Ohtake, Y | 1 |
| Fukuse, T | 1 |
| Hoff, PM | 1 |
| Pazdur, R | 1 |
| Benner, SE | 1 |
| Canetta, R | 1 |
| Kanematsu, T | 2 |
| Terazaki, Y | 1 |
| Kuninaka, S | 1 |
| Hirota, F | 1 |
| Hosaka, K | 1 |
| Funahashi, K | 1 |
| Oota, M | 1 |
| Ikeda, A | 1 |
| Oobayashi, Y | 1 |
| Inada, Y | 1 |
| Murai, M | 1 |
| Hoshino, K | 1 |
| Morishita, Y | 1 |
| Nakanishi, H | 1 |
| Tsukamoto, T | 1 |
| Tatematsu, M | 1 |
| Yohena, T | 1 |
| Wada, S | 1 |
| Suzuki, K | 1 |
| Nukui, A | 1 |
| Sugaya, Y | 1 |
| Muraishi, O | 1 |
| Tokue, A | 1 |
| Basaki, Y | 4 |
| Murakami, K | 1 |
| Hashimoto, A | 4 |
| Yonekura, K | 4 |
| Yamada, Y | 4 |
| Nishino, H | 1 |
| Kanazawa, T | 1 |
| Tanaka, H | 1 |
| Miyata, M | 1 |
| Kitamura, K | 1 |
| Morita, M | 1 |
| Moriwaki, Y | 1 |
| Takahashi, S | 2 |
| Tsutsumi, Z | 1 |
| Tsutsui, T | 1 |
| Higashino, K | 1 |
| Hada, T | 1 |
| Ohsawa, H | 1 |
| Aiba, K | 1 |
| Sugiyama, K | 1 |
| Mizunuma, N | 1 |
| Ito, Y | 1 |
| Horikoshi, N | 1 |
| Yosimori, K | 1 |
| Yoneda, S | 1 |
| Chikahisa, L | 3 |
| Okabe, S | 3 |
| Miyadera, K | 3 |
| Aoyagi, K | 3 |
| Langer, CJ | 2 |
| Sadamoto, Y | 1 |
| Koujima, M | 1 |
| Itaba, S | 1 |
| Miyagi, Y | 2 |
| Imamura, M | 1 |
| Motosato, K | 1 |
| Siomichi, S | 1 |
| Amagase, Y | 1 |
| Tsukamoto, S | 1 |
| Takahashi, N | 1 |
| Takeuchi, M | 1 |
| Seki, Y | 1 |
| Yoshioka, H | 1 |
| Yamada, K | 1 |
| Nishimura, G | 1 |
| Yanoma, S | 1 |
| Mizuno, H | 1 |
| Satake, K | 1 |
| Tsukuda, M | 1 |
| Kusama, M | 1 |
| Kaise, H | 1 |
| Nakayama, S | 2 |
| Oota, D | 1 |
| Koyanagi, Y | 1 |
| Matsunaga, T | 1 |
| Nakamura, Y | 2 |
| Katayama, A | 1 |
| Mafune, K | 1 |
| Makuuchi, M | 1 |
| Wierzba, K | 2 |
| Lewis, NL | 1 |
| Meropol, NJ | 1 |
| Iwamoto, M | 1 |
| Niiya, F | 1 |
| Nagata, S | 1 |
| Odou, E | 1 |
| Hayabuchi, N | 1 |
| Kawano, Y | 1 |
| Li, M | 1 |
| Inui, K | 1 |
| Haseme, E | 1 |
| Shohkei, O | 1 |
| Ohnishi, Y | 1 |
| Kikuchi, K | 1 |
| Nozoe, Y | 1 |
| Ishihama, H | 1 |
| Ishikura, H | 1 |
| Kondo, K | 1 |
| Kinoshita, H | 1 |
| Takahashi, Y | 1 |
| Fujino, H | 1 |
| Monden, Y | 1 |
| Nukatsuka, M | 1 |
| Okada, S | 1 |
| Kuriyama, H | 1 |
| Taguchi, H | 1 |
| Takaoka, K | 1 |
| Matsuda, M | 1 |
| Sawada, Y | 1 |
| Iwamoto, S | 2 |
| Yurino, N | 1 |
| Murai, N | 1 |
| Okuno, F | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Fukuoka, H | 2 |
| Takeda, M | 1 |
| Nomura, S | 1 |
| Ogawa, T | 1 |
| Sakanishi, S | 1 |
| Ueda, T | 1 |
| Kumazawa, J | 1 |
| Ohmori, A | 1 |
| Sakamoto, K | 1 |
| Aito, K | 1 |
| Morita, I | 1 |
| Ohta, Y | 1 |
| Takesue, T | 1 |
| Hara, S | 1 |
| Sagiyama, K | 1 |
| Kayama, T | 1 |
| Sakurai, Y | 1 |
| Ogawa, A | 1 |
| Wada, T | 1 |
| Hara, M | 1 |
| Akimoto, M | 1 |
| Wiebe, LI | 2 |
| Knaus, EE | 2 |
| Gati, WP | 1 |
| Iwashina, T | 1 |
| McQueen, L | 1 |
| Kanda, K | 1 |
| Waki, S | 1 |
| Uchimura, M | 1 |
| Kida, H | 1 |
| Narita, K | 1 |
| Harada, N | 1 |
| Udintsev, SN | 1 |
| Shakhov, VP | 1 |
| Sakamoto, S | 1 |
| Kusuyama, H | 1 |
| Numa, H | 1 |
| Okada, K | 1 |
| Li, XB | 1 |
| Hamada, J | 2 |
| Takeichi, N | 2 |
| Hosokawa, M | 2 |
| Kono, A | 1 |
| Hara, Y | 1 |
| Furusawa, M | 1 |
| Yamakawa, M | 1 |
| Niibe, H | 1 |
| Honjo, J | 1 |
| Kazumoto, T | 1 |
| Akimoto, T | 1 |
| Furuta, M | 1 |
| Yonome, I | 1 |
| Kawaharada, U | 1 |
| Bobek, M | 1 |
| An, SH | 1 |
| Skrincosky, D | 1 |
| De Clercq, E | 1 |
| Bernacki, RJ | 1 |
| Atassi, G | 1 |
| Maruyama, T | 1 |
| Nakatsuru, K | 1 |
| Kitamura, T | 1 |
| Shigehira, M | 1 |
| Tsuda, K | 1 |
| Hidaka, Y | 1 |
| Abrams, DN | 1 |
| Lee, YW | 1 |
| Mercer, JR | 1 |
| Ninomiya, Y | 1 |
| Ryu, M | 1 |
| Matsuura, N | 1 |
| Fujimoto, K | 2 |
| Fukuda, H | 1 |
| Kimura, K | 1 |
| Inoue, I | 1 |
| Noda, Y | 1 |
| Hojo, F | 1 |
| Yagi, M | 1 |
| Nakanishi, S | 1 |
| Yamasaki, K | 1 |
| Inoue, S | 1 |
| Takahashi, K | 1 |
| Yamanaka, A | 1 |
| Oiwa, T | 1 |
| Keicho, N | 1 |
| Saijo, N | 1 |
| Sasaki, Y | 1 |
| Tamura, T | 1 |
| Sakurai, M | 1 |
| Sano, T | 1 |
| Hoshi, A | 1 |
| Aota, M | 1 |
| Jinno, K | 1 |
| Daitoh, N | 1 |
| Nagamatsu, Y | 1 |
| Nakarai, I | 1 |
| Matsuo, T | 1 |
| Shinoda, A | 1 |
| Anai, H | 1 |
| Maehara, Y | 1 |
| Kusumoto, H | 1 |
| Masuda, H | 1 |
| Sugimachi, K | 1 |
| Futatsuki, K | 1 |
| Komita, T | 1 |
| Kamano, T | 1 |
| Watanabe, H | 1 |
| Ogawa, J | 4 |
| Inoue, H | 5 |
| Shohtsu, A | 4 |
| Masuda, F | 1 |
| Nakada, J | 1 |
| Mochizuki, A | 1 |
| Kondo, I | 1 |
| Sugawara, T | 1 |
| Sakuramoto, T | 1 |
| Fukushima, S | 1 |
| Kimoto, M | 1 |
| Kasai, Y | 1 |
| Seo, Y | 1 |
| Shimizu, H | 1 |
| Mure, T | 1 |
| Nobutou, H | 1 |
| Sano, K | 1 |
| Goto, A | 1 |
| Murai, T | 1 |
| Kitamura, H | 1 |
| Komatsumoto, M | 1 |
| Li, S | 1 |
| Okayasu, T | 1 |
| Tanabe, T | 1 |
| Tsurumi, T | 1 |
| Koide, S | 3 |
| Kawada, S | 3 |
| Urabe, N | 1 |
| Momiki, S | 1 |
| Shiba, M | 1 |
| Fidler, IJ | 1 |
| Lieber, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Adjuvant Chemotherapy Versus Observation in Fully Resected Stage I Lung Adenocarcinoma With High Risk of Post-operative Recurrence[NCT03380468] | Phase 2/Phase 3 | 300 participants (Anticipated) | Interventional | 2018-01-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
25 reviews available for uracil and Lung Neoplasms
| Article | Year |
|---|---|
[A Case of Recurrent Rectal Cancer with Adrenal and Lung Metastasis with More than Ten-Year Survival after Surgery].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Chemotherap | 2017 |
[Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2013 |
Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung | 2009 |
Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials as To | 2009 |
UFT and S-1 for treatment of primary lung cancer.
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; | 2010 |
[A case of drug-induced eosinophilic pneumonia due to tegafur-uracil(UFT®)].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Female | 2011 |
[Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 2003 |
Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, | 2004 |
[Concurrent chemoradiation using daily low-dose CDDP and UFT-E for postoperative recurrent esophageal cancers].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell | 2004 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoth | 2005 |
Adjuvant chemotherapy for non-small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 2003 |
Adjuvant chemotherapy for resected non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2005 |
[Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Combinations; Ev | 2006 |
[Adjuvant chemotherapy for non-small cell lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chem | 2006 |
UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Colonic Ne | 2007 |
[Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin | 1996 |
[Fundamental studies on the surgical adjuvant chemotherapy to support the clinical efficacies].
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast N | 1997 |
[Adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined | 1997 |
UFT: biochemical modulation for 5-fluorouracil (5-FU).
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as | 1997 |
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Smal | 1998 |
[A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carcinoma, Renal Cell; Chemical and | 1999 |
The role of tegafur/uracil in pulmonary malignancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical | 1999 |
Adrenalectomy for solitary adrenal metastasis from colorectal carcinoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2000 |
Oral fluoropyrimidines in cancer treatment.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colo | 2000 |
The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcino | 2001 |
48 trials available for uracil and Lung Neoplasms
| Article | Year |
|---|---|
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101).
Topics: Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Deoxycytidine; Gemcitabine; Humans; Lung Neo | 2021 |
Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2023 |
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Carcinoma, Non-Small-Cell Lung; | 2020 |
Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 2019 |
Phase II study of triplet chemotherapy using Tegafur-Uracil, Vinorelbine, Gemcitabine for advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; | 2013 |
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Chemoradioth | 2014 |
Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2008 |
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
Topics: Administration, Oral; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2009 |
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carci | 2011 |
A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dise | 2011 |
Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2012 |
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherap | 2012 |
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2002 |
A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up St | 2003 |
Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2003 |
A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free S | 2004 |
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2004 |
Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; | 2004 |
Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2004 |
A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)--the 4th study.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2005 |
Role of adjuvant chemotherapy in the treatment of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2005 |
[Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chronothe | 2005 |
UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; | 2005 |
Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, No | 2005 |
Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 2006 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplat | 2007 |
Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 2008 |
Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell | 2007 |
Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 2008 |
Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell | 2008 |
[Clinical trial of UFT against disseminated breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 1984 |
A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 1995 |
A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1995 |
[Chemotherapy with oral etoposide, UFT and carboplatin in non-small cell lung cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 1994 |
Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineo | 1996 |
[A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 1996 |
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carci | 1997 |
Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Humans; Japan; Lung Neopla | 1997 |
UFT plus cisplatin in advanced non-small-cell lung cancer: interim analysis of 67 patients.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cispla | 1997 |
Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel | 1997 |
Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 1999 |
UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplat | 1999 |
[Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carci | 1999 |
UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma: a multiinstitutional phase II trial. For the Japan UFT Lung Cancer Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carci | 2000 |
Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; | 2002 |
A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel | 2002 |
[Clinical study of UFT chemotherapy in renal cancer. Kyushu University Cooperative Study Group of Renal Cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration | 1990 |
[Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 1990 |
171 other studies available for uracil and Lung Neoplasms
| Article | Year |
|---|---|
Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Mo | 2019 |
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
Topics: Actinin; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, T | 2022 |
Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy.
Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chem | 2022 |
[Long-Term Response to UFT/UZEL/Bevacizumab Therapy for Lung Metastasis after Surgery for Early-Stage Colon Cancer in a Late-Stage Elderly Patient].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Humans; Leucov | 2022 |
Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2023 |
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2023 |
Tegafur-uracil-induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report.
Topics: Adenocarcinoma of Lung; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Male; Middle Aged; Pericardi | 2021 |
The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Neo | 2017 |
Feasibility Trial of Oral UFT after Platinum-based Adjuvant Chemotherapy in Patients with Resected Non-small Cell Lung Cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2017 |
The Tradition of the Rising Sun: When Geography Counts.
Topics: Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Geography; Humans; Lung Neoplas | 2018 |
Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; | 2018 |
Toxicity and Efficacy of Sequential Chemotherapy in Patients with p-stage I Non-small Cell Lung Cancer that Recurring during Postoperative Tegafur-Uracil Adjuvant Chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2018 |
[A Case of Interstitial Pneumonitis Induced by TAS-102 for Liver and Lung Metastasis of Colorectal Cancer].
Topics: Aged; Drug Combinations; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Male; | 2018 |
Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.
Topics: Artifacts; Carcinoma, Squamous Cell; CpG Islands; DNA; Formaldehyde; High-Throughput Nucleotide Sequ | 2013 |
[A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; H | 2014 |
SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation.
Topics: Adenocarcinoma; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Gene Expression Regulation, Neo | 2014 |
Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva | 2015 |
[Results of a Special Drug Use-Results Survey on Compliance to Tegafur/Uracil(UFT)Adjuvant Chemotherapy for Non-Small Cell Lung Cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 2015 |
[An Elderly Patient with Multiple Lung Metastases after Colectomy Successfully Treated with a Combination Oral UFT/LV Chemotherapy Regimen].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Female; Humans; Leucov | 2016 |
[A Case of Metastatic Colorectal Cancer Refractory to Standard Chemotherapies Treated with TAS-102 with Bevacizumab].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Combined Modality Therapy; Drug Combina | 2016 |
[A patient in whom oral UFT/Leucovorin therapy proved markedly effective for lung metastasis after surgery for colon cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Human | 2008 |
Gemcitabine plus UFT combination chemotherapy as second- or third-line therapy in non-small cell lung cancer: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycy | 2008 |
[A case of metastatic lung and liver tumors from rectal cancer treated with oral UFT and CPT-11 by hepatic arterial infusion followed by FOLFOX and FOLFIRI].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptotheci | 2008 |
[A case of disease-free survival with low-dose chemotherapy after resection of hepatic and pulmonary metastases from rectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Hepatectomy; Humans; Liver Ne | 2009 |
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; | 2010 |
[A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liv | 2010 |
[Tegafur-uracil markedly reduced pulmonary metastasis from renal cell carcinoma refractory to sorafenib, interferon and interleukin 2].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Drug | 2010 |
Uracil-Tegafur-induced pleural effusion following lung cancer surgery.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Drug Combinations; Female; Humans | 2010 |
[A case of lung metastases of colon cancer demonstrating complete response for more than five years after treatment with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Femal | 2010 |
[A case of synchronous hepatic and multiple pulmonary metastases from rectal cancer responding completely to UFT therapy after resection of primary and hepatic lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Liver Neo | 2011 |
[A case of drug-induced interstitial pneumonitis after chemotherapy with UFT and leucovorin for multiple lung metastases of rectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Leucovorin; Lung Diseases, Interstitia | 2011 |
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 2011 |
[A case of UFT-induced complete response against multiple lung metastases of hepatocarcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neopl | 2011 |
[A case of lung metastases after surgery for colon cancer demonstrating complete response for more than six years after treatment with UFT/LV].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Leucovorin; Lung | 2011 |
[Complete disappearance of pulmonary metastases in a case of rectal cancer treated with oral tegafur-uracil (UFT) and leucovorin (LV)].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Humans; Leucovorin; Lung Neopl | 2012 |
Surgical resection of a metastatic skull tumor from lung cancer.
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Smal | 2012 |
Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dihydrouraci | 2002 |
[A case of unresectable rectal cancer with liver and pulmonary metastases that responded remarkably to pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 2002 |
[A case of preoperative concurrent chemoradiotherapy and curative resection for locally advanced non-small-cell lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisp | 2002 |
[A case of colon metastasis to the lung treated successfully with combined chemotherapy of CPT-11 and 5'-DFUR].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Sc | 2002 |
Prognostic significance of p53 status in non-small cell lung cancer in correlation with postoperative adjuvant therapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Smal | 2002 |
[Two patients with recurrent colon cancer who underwent surgery following a combination of irinotecan and UFT].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptoth | 2002 |
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcino | 2003 |
[Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administra | 2003 |
[A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2003 |
[UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel | 2003 |
[A case of multiple lung metastases from colon cancer after sigmoidectomy treated effectively by chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Drug Administration Sc | 2003 |
The potentiation of radiation effects with 5-fluoro-uracil.
Topics: Aged; Carcinoma, Squamous Cell; Esophagitis; Fluorouracil; Humans; Lung; Lung Neoplasms; Male; Middl | 1960 |
Combined therapy of inoperable lung carcinoma with 5-fluorouracil and irradiation.
Topics: Antineoplastic Agents; Fluorouracil; Lung Neoplasms; Psychotherapy, Multiple; Uracil | 1961 |
DEOXYRIBOSYL TRANSFER. I. THYMIDINE PHOSPHORYLASE AND NUCLEOSIDE DEOXYRIBOSYLTRANSFERASE IN NORMAL AND MALIGNANT TISSUES.
Topics: Animals; Breast Neoplasms; Carcinoma; Carcinoma, Ehrlich Tumor; Cattle; Colonic Neoplasms; Cricetina | 1964 |
Combined radiation-chemotherapy for bronchogenic carcinoma--pilot study.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Bronchogenic; Dactinomycin; Folic Acid Antagonists; Hum | 1962 |
[A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sche | 2003 |
Adjuvant chemotherapy for adenocarcinoma of the lung--is the standard of care ready for change?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chem | 2004 |
Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery.
Topics: Animals; Bone Neoplasms; Bystander Effect; Carcinoma, Lewis Lung; Cell Hypoxia; Cytosine Deaminase; | 2004 |
Uracil-tegafur in early-stage lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Lung | 2004 |
Uracil-tegafur in early-stage lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Lung | 2004 |
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Combinati | 2004 |
Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents, Alkylating; Antineoplast | 2005 |
[Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 2005 |
UFT inhibits lung metastases in spontaneous metastasis model of lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Drug Combinat | 2005 |
[A case with advanced carcinoma of the gallbladder responding to UFT monotherapy].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Drug Combinations; Fem | 2005 |
Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cell L | 2005 |
Pulmonary cryptococcosis mimicking pulmonary metastases in a patient treated with Tegafur-uracil after lung cancer surgery.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Crypto | 2005 |
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemo | 2006 |
[A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colect | 2005 |
[A case of multiple lung metastases of sigmoid colon cancer responding well to oral UFT+leucovorin therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid; Drug Administration Schedule; Drug C | 2005 |
[A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2005 |
Prognostic factors for disease-free survival in pT2N0 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoth | 2006 |
[A case of unresectable non-small cell lung cancer with pleural dissemination successfully treated with DIF].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration | 2006 |
[Second-line chemotherapy with pharmacokinetic modulating chemotherapy for unresectable colorectal carcinoma recurrences resistant to 5-FU-based chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronotherapy; Co | 2006 |
[Complete response to CPT-11 and UFT/LV combination therapy in a case with simultaneous multiple lung metastases from colon cancer].
Topics: Adenocarcinoma; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neop | 2006 |
Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small | 2006 |
[Two metastatic colonic cancer patients successfully treated by combination therapy of tegafur/uracil (UFT) and oral Leucovorin].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colon, S | 2006 |
Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.
Topics: Animals; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, | 2007 |
Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; | 2007 |
[Superficial bladder cancer with lung metastasis without local invasion: a case report].
Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Agents; BCG Vaccine; Carcin | 2007 |
[Differences in the therapeutic strategies for lung cancer between Europe/United States and Japan].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carc | 2007 |
[Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administratio | 2007 |
[An elderly case of advanced cervical esophageal cancer successfully treated with UFT after chemoradiotherapy with docetaxel/5-FU/CDDP].
Topics: Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combi | 2007 |
[A case of unresectable colon cancer responding to oral leucovorin+oral tegafur/uracil].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid | 2007 |
[Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Adm | 2007 |
Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; ErbB R | 2007 |
Dramatic response to uracil-tegafur (UFT) in an elderly patient with nonsmall cell lung cancer.
Topics: Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell | 2007 |
[A long-term surviving patient with unresectable lung metastasis from colon cancer treated with intravenous administration of activated autologous lymphocytes and low-dose chemotherapy--a case report].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Com | 2007 |
[Two cases of recurrent colorectal cancer treated successfully with folinate/tegafur/uracil (UFT/LV) chemotherapy on an outpatient basis].
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal | 2008 |
Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine.
Topics: Animals; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Drug Synergism; Female; Floxuridine | 1984 |
[Clinical experiences with UFD-1].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 1982 |
Oxidative modification of DNA bases in rat liver and lung during chemical carcinogenesis and aging.
Topics: 2-Acetylaminofluorene; Adenine; Aging; Animals; Antineoplastic Agents; Disease Models, Animal; DNA D | 1995 |
[A case of bilateral multiple lung metastases from breast cancer successfully treated with carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Femal | 1995 |
[A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1994 |
Oral administration of BOF-A2 to rats with lung transplanted tumors results in increased 5-fluorouracil levels.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Disease Models, Animal; Drug Combinations; Dru | 1994 |
[Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; | 1994 |
Nucleosides and nucleotides. 123. Synthesis of 1-(2-deoxy-2-isocyano-beta-D-arabinofuranosyl)cytosine and related nucleosides as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cytarabine; Deoxycytidine; Drug Stability; Humans; Isocyanates; Leuk | 1993 |
[A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion versus orally UFT in plasma of same patients].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms | 1993 |
[Chemotherapy with cisplatin and daily administration of UFT for unresectable non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, | 1993 |
[Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols | 1993 |
[Experimental study on the combined treatment of UFT with etoposide against mouse Lewis lung carcinoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; DNA, Neoplasm; Etoposide; Lung | 1993 |
[A case of breast cancer with thrombosis during treatment of lung metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug A | 1993 |
[Disease-free survival in a patient with squamous cell lung carcinoma following complete response with the combination chemotherapy of cisplatin and etoposide].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, | 1993 |
Nucleoside analogues. 13. The effect on anti-tumour activity of varying the uracil 5-substituent and the point of attachment (N1 or N3) of the uracil moiety in seco-nucleoside nitrosoureas.
Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Female; Lung Neoplasms; Male; Mammary Neoplasm | 1993 |
[Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon-alp | 1993 |
Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: have we made progress?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Smal | 1996 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Lung Ne | 1996 |
[A case report of concomitant UFT-E and CDDP against lung epidermoid carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisp | 1996 |
[Pulmonary metastasis from renal cell carcinoma diagnosed by using thoracoscopic biopsy: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Renal Cell; Female; Humans; | 1998 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepat | 1998 |
[Complete disappearance of metastatic pulmonary tumors in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1998 |
[Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L | 1998 |
[Results of combination therapy of UFT-E with low-dose CDDP for patients with advanced recurrent breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 1998 |
Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, | 1998 |
[Outpatient chemotherapy with oral UFT (tegafur and uracil) and cisplatin against metastatic non-small cell lung carcinoma--an effective case].
Topics: Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Ne | 1999 |
[Effective treatment of AFP-producing lung cancer with UFT].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Ag | 1999 |
[Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 1999 |
Chemosensitivity of micrometastases and circulating tumor cells to uracil and tegafur as evaluated using LacZ gene-tagged Lewis lung carcinoma cell.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Carcinoma, Lewis Lung; Cinnamates; H | 1999 |
[Anti-metastatic and anti-angiogenic activity of UFT in a lung spontaneous metastasis model in mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Kidney Neoplasms; Lu | 1999 |
Effect of TEI-6720, a xanthine oxidase inhibitor, on the nucleoside transport in the lung cancer cell line A549.
Topics: Allopurinol; Biological Transport; Carrier Proteins; Drug Interactions; Enzyme Inhibitors; Febuxosta | 2000 |
[Effective and low toxicity chemoradiotherapy for distant metastatic esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 1999 |
[Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Neo | 2000 |
Experimental postoperative adjuvant chemotherapy by UFT using primary tumor amputation model.
Topics: Amputation, Surgical; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinom | 2000 |
[A case of advanced hepatocellular carcinoma with lung and bone metastases effectively treated by orally administered UFT].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 2000 |
[A case of epithelial cancer of the alveoli which responded favorably to the additional administration of UFT for refractory cancer after administration of carboplatin and docetaxel].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combi | 2000 |
[An successful case of combined daily oral administration of UFT and low-dose etoposide for multiple metastases of lung cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug | 2000 |
Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy | 2000 |
[A case of postoperative lung and pleural recurrence after 20 years in a breast cancer patient with marked response to orally administered UFT and cyclophosphamide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cycloph | 2000 |
UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.
Topics: Air Sacs; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Assay; Carcinoma, Rena | 2000 |
[A case of pulmonary metastases of breast cancer responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Ad | 2000 |
Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Divi | 2001 |
[Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; | 2001 |
[Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Combinations; Drug Screening Assays, Antitum | 2001 |
[A case of breast cancer with multiple metastases effectively treated with long-term administration of docetaxel, aclarubicin and UFT].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast | 2001 |
Suppression of mediastinal metastasis by uracil-tegafur or cis-diamminedichloroplatinum(II) using a lymphogenous metastatic model in a human lung cancer cell line.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Ne | 2001 |
[Antimetastatic and antitumor effects of fluoropyrimidines alone and combined with taxanes in a murine model of breast cancer metastatic to the lung].
Topics: Aminoacridines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brea | 2002 |
gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma; Carc | 2001 |
[A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; C | 1992 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1991 |
[Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Female; Humans; Lung N | 1991 |
[A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Renal Cell; Humans; Kidn | 1990 |
[Therapy on pulmonary metastasis of renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Thera | 1990 |
Drug-induced perturbations in the in vivo distribution of oncological radiotracers--II. 5-[125I]iodo-2'-deoxyuridine influenced by nitrobenzylthioinosine-5'-phosphate (NBMPR-P) and acyclothymidine (ACT).
Topics: Animals; Idoxuridine; Inosine; Iodine Radioisotopes; Lung Neoplasms; Male; Mice; Neoplasm Transplant | 1990 |
[A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neopla | 1990 |
[Changes in clonogenic properties of bone marrow and transplantable mice tumor cells during combined use of cyclophosphane and biological response modifiers of adaptogenic origin].
Topics: Animals; Bone Marrow; Bone Marrow Cells; Carcinoma, Ehrlich Tumor; Carcinosarcoma; Colony-Forming Un | 1990 |
[Lung metastases of prostatic cancer vanished by early combined hormonal and chemotherapy: report of a case].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality T | 1989 |
[Timing of UFT administration combined with surgical operation in pulmonary metastasis of rat mammary carcinoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Lung Neo | 1989 |
[Effect of uracil on the both reactions, 5-fluorouracil degradation into 2-fluoro-beta-alanine and 5-fluorouracil splitting from tegafur in human tumor].
Topics: Adenocarcinoma, Papillary; Alanine; beta-Alanine; Fluorouracil; Humans; Lung Neoplasms; Tegafur; Tum | 1989 |
[Experimental studies on the combined effect of radiation and UFT 1. Radiosensitizing effect of UFT under single X-ray exposure].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Evaluation Studi | 1989 |
2'-Fluorinated isonucleosides. 1. Synthesis and biological activity of some methyl 2'-deoxy-2'-fluoro-2'-pyrimidinyl-D-arabinopyranosides.
Topics: Animals; Arabinonucleosides; Chemical Phenomena; Chemistry; Chemistry, Physical; Chlorine; Female; F | 1989 |
Nucleoside analogues. 9. Seco-nucleoside analogues of some 5-fluorouracil/nitrosourea molecular combinations having uracil as base: synthesis and anti-tumour activity.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Chemical Phenomena; Chemistry; Colonic Neo | 1989 |
[Almost complete disappearance of metastatic pulmonary tumor and reduction of the main hepatic mass in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Fem | 1987 |
Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracil.
Topics: Animals; Carbon Radioisotopes; Carcinoma 256, Walker; Chlorine; Deoxyuridine; Floxuridine; Lung Neop | 1986 |
[Antitumor activity and toxicity to the immune system and intestine, of the fluorinated pyrimidines FUra, 5'-DFUR, tegafur and UFT].
Topics: Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marro | 1988 |
[Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Floxuridine; Fluorouraci | 1988 |
[A phase II study of UFT in non-small cell lung cancer].
Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small | 1986 |
[UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Female; | 1987 |
[5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluoroura | 1986 |
Phase II study of UFT in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lung N | 1986 |
[Serum and tissue concentrations of UFT in patients with lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymph No | 1986 |
[A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Humans; Liver | 1986 |
[Chemosensitivity testing for 5-FU and 5-FU derivatives using subrenal capsule assay].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colony-Forming Units Assay; Fluor | 1987 |
[Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast | 1987 |
[Interactions between UFT and anticoagulants].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NAD+); Drug Interaction | 1987 |
[Clinical results of UFT fine granule therapy by cooperative study. Osaka UFT Granulation Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capsules; Drug Admini | 1987 |
[Complete regression of pulmonary metastasis from renal cell carcinoma following treatment with UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Hu | 1987 |
[Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Lun | 1987 |
[A case of colon cancer with pulmonary metastasis treated effectively by uracil futraful].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; L | 1988 |
[Complete remission of advanced renal cell carcinoma by chemotherapy and surgical treatment: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Combined Modality | 1987 |
[Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Flu | 1988 |
Interactions between UFT and anticoagulants in lung cancer patients.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Drug Therap | 1988 |
[A sensitivity test of UFT and FT-207 against human pulmonary cancer using nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Screening Assays, Anti | 1988 |
[Experimental and clinical study of interactions between fluorinated pyrimidine derivatives and anticoagulants].
Topics: Animals; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug | 1988 |
[Clinical results of UFT plus anticoagulants as a postoperative adjuvant in lung cancer patients].
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Humans; Lung Neoplas | 1988 |
Quantitative analysis of the mechanism of glucocorticoid enhancement of experimental metastasis.
Topics: Animals; Cell Transformation, Neoplastic; Cells, Cultured; Glucocorticoids; Iodine Isotopes; Lung; L | 1972 |